- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06684938
US Guided Sacroiliac Joint Injection
November 15, 2025 updated by: Sherine Elsherif, Alexandria University
Predictors of Outcome for Sacroiliac Joint Injection With Local Anaesthetic and Corticosteroids in Sacroiliac Joint Pain Patients
Sacroiliac joint (SIJ) pain is one of the underappreciated causes of low back pain.
Recent studies have reported excellent outcomes after Ultrasound (US) guided SIJ injection with local anesthetics and corticosteroids, but these studies are characterized by wide variability in selection criteria and patient characteristics; therefore, there is a need to determine whether any demographic or clinical variables can be used to predict US-guided SIJ injection outcomes.
Study Overview
Detailed Description
this study is testing the different predictors related to the patient that could affect his improvement by >50% after US guided SIJ injection with anaesthetic and steroids
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt
- Alexandria University
-
Alexandria, Egypt, 21529
- Sherine El-Sherif
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- sacroiliac pain
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: sacroiliac injection
anaesthetic and steroid injection into the SIJ through US guidance
|
sacroiliac injection with local anaesthetic and corticosteroids
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postinjection sacroiliac pain intensity
Time Frame: 3 months
|
using Visual analogue scale for pain
|
3 months
|
|
postinjection disability questionnairre
Time Frame: 3 months
|
using Modified Oswestry disability Questionnairre
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: SHERINE EL-SHERIF, Alexandria University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Actual)
November 30, 2024
Study Completion (Actual)
November 30, 2024
Study Registration Dates
First Submitted
October 15, 2024
First Submitted That Met QC Criteria
November 10, 2024
First Posted (Actual)
November 12, 2024
Study Record Updates
Last Update Posted (Actual)
November 18, 2025
Last Update Submitted That Met QC Criteria
November 15, 2025
Last Verified
September 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0107462
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.